IP Library Granted Patent US 9,272,994
Granted Patent B1
US 9,272,994 · App. 14/134,504 · Granted Mar 1, 2016

Ginger metabolites and uses thereof

Inventors: Shengmin Sang (Concord, NC); Huadong Chen (Kannapolis, NC); Yingdong Zhu (Kannapolis, NC)
Assignee: North Carolina A&T State University
C07C323/58A23L1/3002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,272,994
App. No.
14/134,504
Granted
Mar 1, 2016
Kind
B1
Abstract

The present application generally relates to the use of metabolites of ginger and analogs thereof for the treatment and prevention of diseases, including but not limited to, cancer.

Claims (17)

1. A compound having the formula:

wherein n is selected from the group of 2, 4, 6 and combinations thereof; and

the compound is in an isolated or purified form.

2. The compound of claim 1 as a pharmaceutically acceptable salt.

3. The compound of claim 1 as a pharmaceutically acceptable hydrate.

4. A pharmaceutical composition comprising a unit dose of an active ingredient and a pharmaceutical grade carrier wherein said active ingredient is a compound having the formula:

and wherein n is selected from the group consisting of 2, 4, 6 and combinations thereof.

5. The pharmaceutical composition of claim 4 , wherein said active ingredient is a pharmaceutically acceptable salt or hydrate of said formula.

6. The pharmaceutical composition of claim 4 , wherein said compound is in an isolated or purified form.

7. A nutraceutical composition comprising an active ingredient and a food grade carrier wherein said active ingredient is a compound having the formula:

and wherein n is selected from the group consisting of 2, 4, 6 and combinations thereof.

8. The nutraceutical composition of claim 7 , wherein said active ingredient is a pharmaceutically acceptable salt or hydrate of said formula.

9. The nutraceutical composition of claim 7 , wherein said compound is in an isolated or purified form.

10. The nutraceutical composition of claim 7 wherein n consists essentially of 2 and 4.

11. The nutraceutical composition of claim 7 wherein n consists essentially of 2 and 6.

12. The nutraceutical composition of claim 7 wherein n consists essentially of 4 and 6.

13. The nutraceutical composition of claim 7 wherein n consists essentially of 2, 4 and 6.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2014
From: SANG, SHENGMIN; CHEN, HUADONG; ZHU, YINGDONG
To: NORTH CAROLINA A&T STATE UNIVERSITY
Reel/Frame 032632/0305 →
CONFIRMATORY LICENSE Recorded Mar 6, 2014
From: NORTH CAROLINA AGRI & TECH ST UNIV
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 032364/0063 →
Continuity (2)
Provisional Application 61739169 · Dec 19, 2012
Provisional Application 61790291 · Mar 15, 2013